227 related articles for article (PubMed ID: 32695560)
21. Methotrexate-associated lymphoproliferative disorder: A rare pancreatic tumor diagnosed via endoscopic ultrasound-guided fine-needle biopsy.
Kitagawa K; Oyama M; Asada S; Sato S; Nakatani T; Nishimura N; Mui Y; Hanatani JI; Takeda M; Yoshiji H
DEN Open; 2024 Apr; 4(1):e346. PubMed ID: 38444882
[TBL] [Abstract][Full Text] [Related]
22. Methotrexate-related lymphoproliferative disorder of the stomach in a patient with rheumatoid arthritis: a case of disease regression after methotrexate cessation.
Ikeda K; Nakamura T; Kinoshita T; Fujiwara M; Uose S; Someda H; Miyoshi T; Io K; Nagai K
Clin J Gastroenterol; 2016 Feb; 9(1):17-21. PubMed ID: 26733461
[TBL] [Abstract][Full Text] [Related]
23. Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.
Tajima S; Takanashi Y; Koda K; Fukayama M
Pathol Int; 2015 Dec; 65(12):661-5. PubMed ID: 26459854
[TBL] [Abstract][Full Text] [Related]
24. Three different CT and FGD PET/CT findings of pulmonary involvement in methotrexate-associated lymphoproliferative disease.
Matsubayashi S; Suzuki M; Sakamoto K; Izumi S; Hojo M; Sugiyama H
Respirol Case Rep; 2020 Mar; 8(2):e00520. PubMed ID: 31956414
[TBL] [Abstract][Full Text] [Related]
25. Lymphoproliferative disorder in an elderly rheumatoid arthritis patient after longterm oral methotrexate administration: A case report.
Hashimoto K; Akagi M
Mol Clin Oncol; 2018 Sep; 9(3):293-296. PubMed ID: 30155252
[TBL] [Abstract][Full Text] [Related]
26. Methotrexate-Associated Lymphoproliferative Disease of the Thoracic Spine Misdiagnosed as Metastatic Spinal Tumor: A Case Report.
Tsukamoto M; Morimoto T; Hirata H; Yoshihara T; Mawatari M
Cureus; 2022 Aug; 14(8):e27692. PubMed ID: 36134046
[TBL] [Abstract][Full Text] [Related]
27. Methotrexate-associated orbital lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report.
Kobayashi Y; Kimura K; Fujitsu Y; Shinkawa K; Muta H; Sonoda KH
Jpn J Ophthalmol; 2016 May; 60(3):212-8. PubMed ID: 27018050
[TBL] [Abstract][Full Text] [Related]
28. Methotrexate-associated proliferative disorder in the lower esophagus extending to the gastroesophageal junction: A case report.
Hojo Y; Takatsuna M; Ikarashi S; Kamimura H; Kimura R; Mito M; Watanabe Y; Tani Y; Yokoyama J; Terai S
DEN Open; 2022 Apr; 2(1):e14. PubMed ID: 35310712
[TBL] [Abstract][Full Text] [Related]
29. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.
Ichikawa A; Arakawa F; Kiyasu J; Sato K; Miyoshi H; Niino D; Kimura Y; Takeuchi M; Yoshida M; Ishibashi Y; Nakashima S; Sugita Y; Miura O; Ohshima K
Eur J Haematol; 2013 Jul; 91(1):20-8. PubMed ID: 23560463
[TBL] [Abstract][Full Text] [Related]
30. A case of rheumatoid arthritis with methotrexate related lymphoproliferative diseases of the knee.
Abe A; Wakaki K; Ishikawa H; Ito S; Murasawa A
Mod Rheumatol; 2018 May; 28(3):550-554. PubMed ID: 26558294
[TBL] [Abstract][Full Text] [Related]
31. [Three cases of methotrexate-associated lymphoproliferative disorder (MTX-LPD)].
Ishida Y; Asahi A; Wada T; Kanai N; Kobayashi Y; Moriai S; Kishibe K; Harabuchi Y
Nihon Jibiinkoka Gakkai Kaiho; 2008 Aug; 111(8):594-8. PubMed ID: 18788425
[TBL] [Abstract][Full Text] [Related]
32. Methotrexate-associated Lymphoproliferative Disorders in Patients With Rheumatoid Arthritis: Clinicopathologic Features and Prognostic Factors.
Kurita D; Miyoshi H; Ichikawa A; Kato K; Imaizumi Y; Seki R; Sato K; Sasaki Y; Kawamoto K; Shimono J; Yamada K; Muto R; Kizaki M; Nagafuji K; Tamaru JI; Tokuhira M; Ohshima K
Am J Surg Pathol; 2019 Jul; 43(7):869-884. PubMed ID: 31116708
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
Katsuyama T; Sada KE; Yan M; Zeggar S; Hiramatsu S; Miyawaki Y; Ohashi K; Morishita M; Watanabe H; Katsuyama E; Takano-Narazaki M; Toyota-Tatebe N; Sunahori-Watanabe K; Kawabata T; Miyake K; Kiguchi T; Wada J
Mod Rheumatol; 2017 Sep; 27(5):773-777. PubMed ID: 27846761
[TBL] [Abstract][Full Text] [Related]
34. Vitreoretinal Lymphoma in a Patient with Rheumatoid Arthritis with a History of Methotrexate-associated Lymphoproliferative Disorders.
Kurisu N; Hiyama T; Harada Y; Fukushima N; Katsuya N; Ureshino H; Ichinohe T; Kiuchi Y
Ocul Immunol Inflamm; 2022 Nov; ():1-6. PubMed ID: 36395469
[TBL] [Abstract][Full Text] [Related]
35. Unusual manifestation of methotrexate-associated lymphoproliferative disorder as a palatal mass.
Watanabe T; Teratani Y
BMJ Case Rep; 2022 Sep; 15(9):. PubMed ID: 36175042
[TBL] [Abstract][Full Text] [Related]
36. Methotrexate-associated lymphoproliferative disorder complicated by severe acute respiratory failure and ileal perforation:a case report.
Suzuki E; Kanno T; Kimura S; Irie T; Odajima H; Migita K
Fukushima J Med Sci; 2018 Aug; 64(2):82-88. PubMed ID: 29925726
[TBL] [Abstract][Full Text] [Related]
37. Characteristics and risk factors of lymphoproliferative disorders among patients with rheumatoid arthritis concurrently treated with methotrexate: a nested case-control study of the IORRA cohort.
Shimizu Y; Nakajima A; Inoue E; Shidara K; Sugimoto N; Seto Y; Tanaka E; Momohara S; Taniguchi A; Yamanaka H
Clin Rheumatol; 2017 Jun; 36(6):1237-1245. PubMed ID: 28455827
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous methotrexate-related T-cell lymphoproliferative disorder with CD4, CD30, CD56, EBV-positive tumor cell infiltration: a case illustration and a brief review.
Omori I; Kawanabe R; Hashimoto Y; Mitsui A; Kodama K; Nogi S; Tsuno H; Horita A; Saito I; Ohmatsu H
Am J Blood Res; 2021; 11(2):163-167. PubMed ID: 34079630
[TBL] [Abstract][Full Text] [Related]
39. Oral Methotrexate-related Lymphoproliferative Disease Presenting with Severe Osteonecrosis of the Jaw: A Case Report and Literature Review.
Furukawa S; Oobu K; Moriyama M; Kawano S; Sako S; Hayashida JN; Matsubara R; Ogata KI; Kiyoshima T; Nakamura S
Intern Med; 2018 Feb; 57(4):575-581. PubMed ID: 29225245
[TBL] [Abstract][Full Text] [Related]
40. Methotrexate-associated Lymphoproliferative Disorder of the Stomach Presumed to Be Mucosa-associated Lymphoid Tissue Lymphoma.
Ishigaki S; Masaoka T; Kameyama H; Kawaida M; Kameyama K; Mori T; Kanai T
Intern Med; 2018; 57(22):3249-3254. PubMed ID: 30429434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
